Skip to main content
Home
About Us
Market for Treating AD
Strategy
Background
Management
Management
Board of Directors
Pipeline
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
Events & Presentations
Event Calendar
Financials
Quarterly Reports
Annual Reports
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Site Search
News
Home
About Us
Market for Treating AD
Strategy
Background
Management
Management
Board of Directors
Pipeline
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
Events & Presentations
Event Calendar
Financials
Quarterly Reports
Annual Reports
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Home
About Us
Market for Treating AD
Strategy
Background
Management
Management
Board of Directors
Pipeline
Investor Relations
News
Stock Information
Stock Quote
Historical Stock Quote
Investment Calculator
Events & Presentations
Event Calendar
Financials
Quarterly Reports
Annual Reports
SEC Filings
Corporate Governance
Governance Documents
Board of Directors
Shareholder Services
Investor FAQs
Investor Emails Alerts
Investor Contact
Contact Us
Normal
Press release year list
2021
2020
09/02/2021
Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance
08/02/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
07/12/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
07/01/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
05/10/2021
Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update
05/03/2021
Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update
03/24/2021
Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results and Provides a General Business Update
03/17/2021
Forte Biosciences, Inc. to Announce 4Q and Full Year 2020 Results and Provide a General Business Update
02/23/2021
Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th
02/18/2021
Forte Biosciences, Inc. to Present at the Cowen Annual Health Care Conference on March 1st
02/12/2021
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules